A

Anika Therapeutics
D

ANIK

17.390
USD
-0.25
(-1.42%)
مغلق
حجم التداول
1,038
الربح لكل سهم
0
العائد الربحي
-
P/E
-3
حجم السوق
254,686,914
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABT
    ABT
    1.785
    (1.34%)
    134.950 USD
    B
    BAX
    0.425
    (1.27%)
    33.840 USD
    BDX
    BDX
    -0.590
    (-0.26%)
    227.450 USD
    BSX
    BSX
    -0.840
    (-0.80%)
    104.480 USD
    EW
    EW
    -1.380
    (-1.85%)
    73.300 USD
    ISRG
    ISRG
    -15.37
    (-2.53%)
    591.50 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    SYK
    SYK
    -3.72
    (-0.96%)
    382.74 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    ZBH
    ZBH
    1.250
    (1.21%)
    104.890 USD
    المزيد
الأخبار
المقالات

العنوان: Anika Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.